C. Salcedo

A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma

Miguel D. Ferrer, M. Mar Perez, M. M. Cànaves et al. · Scientific Reports · 2017 · 40 citations · Full text

Medicine, Nephrology, Pharmacology +10

First‐time‐in‐human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification

Joan Perelló, Pieter Joubert, Miguel D. Ferrer et al. · British Journal of Clinical Pharmacology · 2018 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels

Joan Perelló, Miquel Gómez, Miguel D. Ferrer et al. · Journal of Nephrology · 2018 · 31 citations · Full text

Medicine, Biochemistry, Pharmacology +15

SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification

Arsenii Zabirnyk, Miguel D. Ferrer, Maria Bogdanova et al. · Vascular Pharmacology · 2019 · 20 citations · Full text

Medicine, Biochemistry, Cell Biology +13

<i>In vivo</i> and <i>in vitro</i> pharmacological characterization of SVT‐40776, a novel M ₃ muscarinic receptor antagonist, for the treatment of overactive bladder

C. Salcedo, Sandra de Davalillo, Joan Cabellos et al. · British Journal of Pharmacology · 2009 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17